All In Biotech

Drug Trial Radar · NCT03214367

A Study of LY900014 in Participants With Type 1 Diabetes

A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro With an Open-Label Postprandial LY900014 Treatment Group, in Combination With Insulin Glargine or Insulin Degludec, in Adults With Type 1 Diabetes PRONTO-T1D

Last checked: Nov 20, 2026Latest source record: May 1, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,392 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,392

Actual

Start

Jul 17, 2017

Primary completion

Sep 6, 2018

Study completion Aug 22, 2019

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Jul 11, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to evaluate the efficacy of the study drug LY900014 compared to insulin lispro, both in combination with insulin glargine or insulin degludec, in adults with type 1 diabetes (T1D).

Conditions

  • Type 1 Diabetes Mellitus

Interventions

  • LY900014Drug

    Administered SC

  • Insulin LisproDrug

    Administered SC

  • Insulin GlargineDrug

    Administered SC

  • Insulin DegludecDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Hemoglobin A1c (HbA1c) Efficacy Estimand at Week 26Time frame: Baseline, Week 26

Locations

172 sites in 20 countries. Site status is shown where the registry gives one.

  • Internal Medicine Center LLC

    Mobile, Alabama

  • John Muir Physician Network Clinical Research Center

    Concord, California

  • AMCR Institute INC

    Escondido, California

  • Valley Endocrine, Fresno

    Fresno, California

  • Marin Endocrine Associates

    Greenbrae, California

  • Diabetes and Endocrine Associates

    La Mesa, California

  • University Clinical Investigators, Inc.

    Tustin, California

  • Coastal Metabolic Research Centre

    Ventura, California

  • Barbara Davis Center for Childhood Diabetes

    Aurora, Colorado

  • The Center For Diabetes & Endocrine Care

    Fort Lauderdale, Florida

  • East Coast Institute For Research

    Jacksonville, Florida

  • Sun Coast Clinical Research, Inc

    New Port Richey, Florida

  • Metabolic Research Institute Inc.

    West Palm Beach, Florida

  • Atlanta Diabetes Associates

    Atlanta, Georgia

  • East Coast Institute For Research

    Macon, Georgia

  • Endocrine Research Solutions, Inc.

    Roswell, Georgia

  • East West Medical Institute

    Honolulu, Hawaii

  • Northwest Clinical Trials

    Boise, Idaho

  • Rocky Mountain Diabetes and Osteoporosis Center

    Idaho Falls, Idaho

  • Prairie Education and Research Cooperative

    Springfield, Illinois

  • Iderc, P.L.C.

    West Des Moines, Iowa

  • University of Kansas Medical Center

    Kansas City, Kansas

  • Cotton O'Neil Diabetes and Endocrinology Center

    Topeka, Kansas

  • Kentucky Diabetes Endocrinology Center

    Lexington, Kentucky

  • MassResearch

    Waltham, Massachusetts

  • Palm Research Center

    Las Vegas, Nevada

  • Palm Research Center

    Las Vegas, Nevada

  • Southern New Hampshire Diabetes and Endocrinology

    Nashua, New Hampshire

  • Manhattan Medical Research

    New York, New York

  • Physicians East

    Greenville, North Carolina

  • Diabetes & Endocrinology Consultants PC

    Morehead City, North Carolina

  • PMG Research of Wilmington, LLC

    Wilmington, North Carolina

  • Your Diabetes Endocrine Nutrition Group PC

    Mentor, Ohio

  • Lehigh Valley Hospital

    Allentown, Pennsylvania

  • Partners in Nephrology & Endocrinology

    Pittsburgh, Pennsylvania

  • Sudir Bansal M.D. Inc.

    Warwick, Rhode Island

  • University Diabetes and Endocrine Consultants

    Chattanooga, Tennessee

  • Texas Diabetes and Endocrinology

    Austin, Texas

  • Dallas Diabetes Endocrine Center

    Dallas, Texas

  • Texas Diabetes and Endocrinology, P.A.

    Round Rock, Texas

Showing 40 of 172 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.